19 Jun 2009, 0107 hrs IST, Nina Mehta,
MUMBAI: British companies are looking to partner with Indian clinical research organisations (CROs) in a bid to tap the $1 billion (about Rs 4,800 crore) clinical research market in
“The idea is to partner with Indian CROs who have to do a part of their trials in the
Industry observers believe that a partnership will benefit Indian CROs, as they will get guidance on the approvals needed to transport the drug samples while
Shashank Rohatagi, executive director at Daiichi Sankyo India Pharma said, “Doing clinical trials in a place opens up the market in that area for your products. More companies are looking at conducting their trials in
UK-based Cognitive Drug Research (CDR), a provider of systems which allow clinicians to test cognitive functions in patients, is looking to establish a presence in
David Strinati, business development associate at CDR said, “We are looking to partner with CROs and pharma companies, since
“Partnerships can help reduce both time and costs as well as provide access to expertise and other resources. Sponsors will also benefit by focusing on their core competencies,” Mr Rohatagi said.